Last night, I posted the Harvard Symposium Institutional Corruption and Pharmaceutical Policy as soon as I became aware of its existence and read the first entry [a little light reading…]. But now I’ve had the chance to read a few more of the pieces in the list. If you’re a reader of this blog or […]
There’s more than one answer to these questions, Pointing me in a crooked line… Closer to Fine, Indigo Girls 1989 A Dry Pipeline for Psychiatric Drugs New York Times Perspective By RICHARD A. FRIEDMAN, M.D. August 19, 2013 Fully 1 in 5 Americans take at least one psychiatric medication. Yet when it comes to mental […]
No, I haven’t read them all yet either, but they look mighty interesting [they are PDF files]: Institutional Corruption and Pharmaceutical Policy An Edmond J. Safra Center Symposium Harvard University Journal of Law, Medicine and Ethics Vol. 14, No. 3 (2013) Marc Rodwin, Institutional Corruption and Pharmaceutical Policy Lawrence Lessig, Foreword: ‘Institutional Corruption’ Defined Gregg […]
Early Detection of Schizophrenia: The Time Is Now From the President Psychiatry News by Jeffrey Lieberman, M.D. August 15, 2013 Medical research often takes a slow and unpredictable pace. The hours spent defining the question, setting up the experiment, and acquiring and then analyzing the data before getting to see the results makes for a […]
As a beginning psychiatrist, I read Eugen Bleuler’s 1911 description of the premorbid personalities of patients who went on to develop Schizophrenia. He acknowledged that although the personality type [Schizoid Personality] is very often described in the history of Schizophrenic patients, there are many people of the described type that do not develop Schizophrenia. I […]
I told you Jack Friday of Pharmagossip was our man in China [good on China…]: GSK graft probe in China may turn global with American, British interest Analysts say investigation could spread out from China to other firms internationally because those being bribed are typically state workers South China Morning Post by Toh Han Shih […]
After the financial collapse in 2008, I spent some time learning a bit about something that I’d never had time to look into [one of the great pleasures of retirement is that you can think about whatever you want to think about, or think about nothing] – economics. The way our economy works, we require […]
Jack Friday of Pharmagossip has become our go-to man for the goings on in China PHARMA – a story that’s still in its ascendency: China to Launch Fresh Probe of Drug-industry Bribery MoneyNews from Thomson/Reuters 14 Aug 2013 China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a […]
This case is about many things, but my interest is in one particular aspect – that secrecy about Clinical Trial data is justified to protect Trade Secrets. I think that is a bizarre non-argument. The only secrets being protected are that the drug’s efficacy is marginal and that its toxicity has been minimized. Those are […]
Among the graphs that grace these pages, this one remains the most shocking – that the most prescribed drug class by cost to Medicaid is the [Atypical] Antipsychotics. I still find it hard to wrap my mind around this story. In 2008, they list over 600,000 kids on Antipsychotics at a cost of $3.6 B! […]